Concepedia

Publication | Open Access

<i>SULF2</i> strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus

40

Citations

31

References

2013

Year

Abstract

These findings implicate SULF2 as potential therapeutic target in the atherogenic dyslipidemia of obesity and T2DM.

References

YearCitations

Page 1